1. Home
  2. ON vs BNTX Comparison

ON vs BNTX Comparison

Compare ON & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ON Semiconductor Corporation

ON

ON Semiconductor Corporation

HOLD

Current Price

$102.68

Market Cap

34.2B

Sector

Technology

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$98.94

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ON
BNTX
Founded
1992
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
24.2B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
ON
BNTX
Price
$102.68
$98.94
Analyst Decision
Buy
Strong Buy
Analyst Count
25
13
Target Price
$65.29
$133.46
AVG Volume (30 Days)
9.2M
787.1K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$5,878,300,000.00
N/A
Revenue This Year
$7.93
N/A
Revenue Next Year
$8.90
$3.37
P/E Ratio
$346.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.19
$79.81
52 Week High
$101.69
$124.00

Technical Indicators

Market Signals
Indicator
ON
BNTX
Relative Strength Index (RSI) 81.17 47.95
Support Level $46.88 $91.74
Resistance Level N/A $113.05
Average True Range (ATR) 3.70 3.65
MACD 1.69 -0.27
Stochastic Oscillator 99.43 17.99

Price Performance

Historical Comparison
ON
BNTX

About ON ON Semiconductor Corporation

Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: